Search results

Thirty years of ANSTO's unique capability in monitoring fine particle pollution provides insight on bushfire smoke.

ANSTO provides access to specialised facilities and capabilities by application. Please ensure that you contact the relevant ANSTO scientist for advice before submitting a proposal.

Radioactive phosphorous for implantable medical device to treat pancreatic cancer in global clinical trial

Think Science! 2023 Summary and Results

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.

Ultra-realistic simulations of a PET imaging system for next-generation radiotherapy: Collaboration giving back to the open source science community.

Industrial Engagement Manager at ANSTO and Professor in Advanced Structural Materials at the University of Sydney, Anna Paradowska is among the authors who contributed to a 2019 paper that was recently awarded the ASM International ASM Henry Marion Howe Medal in Metallurgical and Materials Transactions A.

You are invited to submit to the various awards from ANSTO and the User Meeting 2026 organising committee. 

This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.

Datasets from the Aerosol Sampling Program.

ANSTO shared plans for an Innovation Precinct in southern Sydney at a breakfast event.